Detection of experimental hepatic tumors using long circulating superparamagnetic particles

Investigative Radiology

Volumn 36, Issue 1, 2001, Pages 15-21

  Sayegh, Yasmine ^a   Pochon, Sibylle ^b   Vallée, Jean Paul ^a   Becker, Minerva ^a   Lazeyras, François ^a   Tournier, Hervé ^b   Hyacinthe, Roland ^b   Fouillet, Xavier ^b   Terrier, François ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Bracco Suisse SA   (Switzerland)

Author keywords

Blood pool; Iron oxide; Magnetic resonance contrast agent; Rabbit; VX2 tumors

Indexed keywords

CONTRAST MEDIUM; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; IMAGE ANALYSIS; LIVER TUMOR; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT; RETICULOENDOTHELIAL SYSTEM; TUMOR DIAGNOSIS; TUMOR VASCULARIZATION;

EID: 0035148566     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200101000-00003     Document Type: Article

References (16)

1. Long circulating superparamagnetic particles with high T2 relaxivity
2. Hepatic MRI with SPIO: Detection and characterization of focal liver lesions
3. Liver-specific MR imaging contrast agents
4. Specific MR contrast media for liver imaging
5. A transplantable rabbit carcinoma originating in a virus-induced papilloma and containing the virus in masked or altered form
6. Experiments on the cause of the rabbit carcinoma derived from virus-induced papilloma. II. Loss by the VX2 carcinoma of the power to immunize hosts against the papilloma virus
7. Age-related changes in tumor vascularity
8. Gray-scale liver enhancement in VX2 tumor-bearing rabbits using BR14, a new ultrasonographic contrast agent
9. Liver positive enhancement after injection of superparamagnetic nanoparticles: Respective role of circulating and uptaken particles
10. Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles
11. Dual contrast enhancement of both T1- and T2-weighted sequences using ultrasmall superparamagnetic iron oxide
12. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: Initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227)
13. Intratumoral vascularity of experimentally induced VX2 carcinoma
14. MRI quantitative myocardial perfusion with compartmental analysis: A rest and stress study
15. Hepatocellular carcinoma: Correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings
16. Safety and pharmacokinetics of a new liposomal liver-specific contrast agent for CT: Results of clinical testing in nonpatient volunteers